Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off
Close

Pharma Mar SAU (0RC6)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
30.62 -0.21    -0.68%
01/03 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 1,212
  • Bid/Ask: 29.86 / 31.38
  • Day's Range: 29.78 - 30.84
Type:  Equity
Market:  United Kingdom
ISIN:  ES0169501022 
SEDOL:  BMXSKX7
Pharma Mar 30.62 -0.21 -0.68%

0RC6 Income Statement

 
Assess the Pharma Mar SAU income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
30/09
2023
30/06
2023
31/03
2022
31/12
Total Revenue 37.45 46.21 33.98 54.94
Revenue 37.64 46.04 33.96 54.95
Other Revenue, Total -0.184 0.165 0.019 -0.006
Cost of Revenue, Total 3.14 1.89 2.13 6.23
Gross Profit 34.31 44.32 31.85 48.71
Total Operating Expenses 37.64 42.16 36.55 53.57
Selling/General/Admin. Expenses, Total 8.89 11.67 9.84 15.1
Research & Development 23.67 25.59 21.06 26.38
Depreciation / Amortization -2.77 1.44 1.33 -3.84
Interest Expense (Income) - Net Operating - - -0.645 -7.41
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 4.7 1.58 2.84 17.11
Operating Income -0.184 4.05 -2.57 1.37
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -1.89
Other, Net -1.75 -0.45 0.645 6.08
Net Income Before Taxes 1.57 4.5 -3.22 -2.82
Provision for Income Taxes 0.049 -0.527 -4.63 -4.21
Net Income After Taxes 1.52 5.02 1.41 1.39
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1.52 5.02 1.41 1.39
Total Extraordinary Items - - - 4.6
Net Income 1.52 5.02 1.41 5.98
Total Adjustments to Net Income - - - -4.6
Income Available to Common Excluding Extraordinary Items 1.52 5.02 1.41 1.39
Dilution Adjustment - - - 4.64
Diluted Net Income 1.52 5.02 1.41 1.34
Diluted Weighted Average Shares - 17.98 - 18.11
Diluted EPS Excluding Extraordinary Items - 0.279 - 0.074
DPS - Common Stock Primary Issue - - - 0.65
Diluted Normalized EPS - 0.156 - -0.101
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PHMR Comments

Write your thoughts about Pharma Mar SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jose Alcaraz
Jose Alcaraz Feb 09, 2021 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Facing 148 again in no time.
Massimo Calvo
Massimo Calvo Feb 09, 2021 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is your assertivity coming from, technically there is no signal it will hapoen
Marc Torras
Marc Torras Feb 07, 2021 21:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will go to the top again
Jose Alcaraz
Jose Alcaraz Feb 03, 2021 16:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up!, Up!, Up!!
Jose Alcaraz
Jose Alcaraz Feb 01, 2021 19:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next step: Phase III for coronavirus antiviral. 🚀🚀🚀
Arvinder Mann
ARVI Oct 30, 2020 8:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
Razaq Shobande
Razaq Shobande Oct 29, 2020 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very bullish
Harry Hanko
Harry Hanko Oct 20, 2020 15:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone know what's happening with this at the moment?
Furquan Ali
Furquan Ali Oct 18, 2020 7:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I found this on trading 212
David Finlay
David Finlay Sep 30, 2020 7:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why cant I find this company on my trading platform?
minanath durge
minanath durge Sep 24, 2020 15:59
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very bullish
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email